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INTRODUCTION 
Glaucoma is a multifaceted disease with limited information on its natural 
course. There are many different management regimens for glaucoma.1 ,2 No 
matter what type of treatment modality is used, present glaucoma management 
is directed at the reduction of IOP,2 and cannot be considered successful 
unless functional vision loss can be controlled, or possibly reversed. Can a 
reversal of clinical findings be achieved? A current article review suggests that 
reversals of optic disk cupping and visual field loss are possible in a large 
enough percentage of patients to warrant consideration. The unpredictable 
progression of the disease, combined with the variability of patient response to 
treatment, poses a difficult management task for the clinician, but one with the 
possibility of a successful outcome. 
As with other diseases, glaucoma presents and follows a working model 
which shows progression with specific signs and symptoms. The classic 
glaucoma model begins with an initial increase in lOP, development of 
abnormalities of the optic disc and, finally, the appearance of visual field 
defects. It should be understood that this model is correct for the majority of 
cases, but not all cases present themselves in this specified way. For example, 
lOP elevation is not necessarily the first indication of glaucoma and significant 
visual field loss can occur in patients whose lOP's are not elevated; as found 
with low tension glaucoma. This suggests that more than one mechanism may 
contribute to the visual field losses associated with glaucoma. 
The glaucomas show a great patient variability regarding progression 
of the disease. Other variabilities include patient reactions to treatment, and 
variability of the lOP needed to prevent further functional vision loss. Goldman 
described a pressure level below which the optic nerve can function for an 
extended period of time without damage as the critical intraocular pressure. The 
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critical lOP differs for each patient, but is the point at which functional vision has 
the greatest opportunity for stability or even reversal.1 At present, there is no 
known way to accurately predict what level, if any, of lOP will be associated 
with the stabilization of the disease and thus stabilization of visual field loss. 
The most popular method of treatment is one of trial and error. The 
intraocular pressure is lowered to a predetermined "normal" amount while 
visual fields are monitored.2 If vision loss still progresses, a more aggressive 
approach is initiated to further reduce the lOP. This management approach 
combined with the precaution against overtreatment due to side effects, tends to 
allow progression of the disease in many cases.2 This universal modality of 
treatment does not take into consideration the individual patient's critical lOP. 
Further study must be made to identify individual factors concerning glaucoma 
treatment. 
The current care of patients with chronic glaucoma is based on a 
conceptual framework in which it is assumed: one, that untreated chronic 
glaucoma is an inexorably progressive disease and two, that the deterioration 
can in some cases be halted by lowering IOP.3 Other studies, discussed later in 
the paper, have documented that decreases in lOP, achieved by different 
agents, may have very different consequences with respect to preservation of 
the visual fields. 6,9 Findings of this type indicate that researchers and clinicians 
must consider multiple modes of glaucoma in designing screening and 
treatment programs for the disease. 
lOP 
Although lOP control is how we attempt to manage glaucoma, it may not be 
the factor that best determines successful outcome. At present, the efficacy of 
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antiglaucoma therapy is usually judged on the basis of its intraocular pressure 
reducing effect. Our literature review stresses the possibility that lowering lOP 
to each individuals' critical pressure can result in improvement of the visual field 
in a large percentage of patients. Clinical experience along with the work of 
other authors, suggests that this is not always the case. 
Rolando and co-workers evaluated the effect of lOP drop and visual field 
changes in the short term. The results showed a visual field deterioration in 
60% of the eyes, visual field improvement in 30% and no change in the final 
10% of cases.4 To add to these percentages is a study by Zeimer, concerning 
the diurinal variation among patients. Approximately 30% of patients with 
glaucomatous visual field loss first present with a "normal" lOP. Patients may 
have an undetected diurnal curve that spikes above the "normal borderline" of 
21 mmHg. Only 40% of POAG patients have their spike between 8:30AM and 
5:00PM,s therefore, a patient may be erroneously diagnosed as having a 
"normal" lOP. Thus, one-third of glaucoma suspects may go undetected until 
physically visible changes occur in the optic nerve or repeatable visual field 
defects are noted. If these percentages resemble the general population, then 
the percentage of visual field improvements, as found by Rolando, could 
possibly be higher with early diagnosis and treatment. 
In another study by Pecori-Giraldi, 55 eyes with pressures of greater than 
24mm were studied. Hypotonia was induced with glycerol, and lOP was 
remeasured. Visual fields were retested when lOP had fallen by 6 to 10 mm Hg 
and maintained with medical therapy for at least 5 months. A significant 
increase in the total sensitivity of the visual field occurred when lOP was 
decreased an average of 8 mm. No significant differences were apparent on 
visual field examinations prior to hypotonization, confirming the latter visual field 
changes were due to lOP reduction and not to chance.e As one may expect, the 
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greater the lOP reduction, the greater the visual field improvement as 
demonstrated in Shin's study where 13 patients were monitored.7 
When reducing the lOP in glaucoma patients, there are two important 
questions. One, how low do I set my goal for lOP reduction?; and two, what 
means of treatment do I select for this lOP reduction? In the previosly mentioned 
study by Pecori-Giraldi, it was reported that in the 55 eyes studied, lOP 
reduction with timolol resulted in visual fields that either remained stable or 
improved over a three year follow-up time. In contrast, patients treated with 
pilocarpine to an eqivalent decrease in lOP showed progressive visual field 
loss. 6 
In conclusion the effect of medical therapy in glaucoma can be evaluated 
in the short term with lOP measurements. Careful visual field examination can 
indicate the efficacy of antiglaucoma therapy which is not always related to lOP 
values. Visual field improvements in glaucoma seem to be a rather frequent 
event, and often are the only indicator of efficacy of therapy.4 
OPTIC CUP 
Optic nerve evaluation is an essential part of the optometric examination and 
unlike other tests, it is a subjective measurement made by the practitioner. The 
majority of early glaucoma changes occur in the optic disc. Such changes 
include increased cup/disc ratio with thinning of the neural rim, vertical 
elongatation of the cup, bearing of circumlinear vessels, striated lamina, and 
bayonetting. It has been shown in studies that cup changes may precede 
changes in pallor due to the loss of nerve tissue.3.B Other studies have shown 
that loss of optic nerve fibers occurs before glaucomatous field loss appears.s 
Stereo photographs and computerized image analysis provide objective 
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quantification of the contour of the optic nerve head and should be used in the 
future evaluation of the optic cup. 
The question as to what occurs first in the glaucomatous eye is a topic 
for further study. The reversal of rim tissue thinning is a question of greater 
relevance when considering the return of functional vision. It seems consistent 
that if there is an improvement in the rim tissue, then a visual field reversal 
should also occur. This was noted by Shin and co-workers who reported that a 
direct correlation existed between the amount of lOP reduction, amount of 
decrease in cup/disc ratio, increase in neuroretinal rim area, and the decrease 
in cup volume.9 The visual field response may not correspond directly to the 
cup/disc ratio changes due to variability of lOP reduction. In a study by Katz, 75 
eyes were studied over a 10 year period and cup/disc ratio improvement was 
noted in nearly one third of the glaucomatous eyes that had at least a 30% 
decrease of lOP. Of those with less than a 20% decrease in lOP, a 0% 
improvement was noted.10 Shin's study also suggested a 50% decrease in lOP 
was needed to cause a decrease in the cup/disc ratio. This data reinforces the 
importance of adjusting treatment for each individual patient. It is not just a 
matter of decreasing the lOP, but rather decreasing lOP a critical amount for 
each patient. Perhaps a critical lOP reduction must be attained before a 
clinically noticeable change in the optic disk can occur. One fact does seem 
consistent; the greater the magnitude of lOP reduction, the greater the reversal 
effect. Those with a low percentage of lOP reduction tend to show no reversal 
and may even show progression.? These studies have shown that lowering 
intraocular pressure can reverse disc cupping. 
It appears that the optic disc cup reversal is complete during the first 2 
weeks of lOP reduction, with little more occurring beyond that time.? A decrease 
in cup volume, an increase in neural rim area, and a decrease in the cup to disc 
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ratio occured within two weeks in 62% of the eyes with POAG after the lOP had 
been reduced by 50% or more. 7 Again a critical lOP reduction had to be 
achieved for visible results. Even though most cup/disc ratio reversals occur in 
the first two weeks of lOP reduction, cup/disc changes have been shown to 
occur later on in the treatment of some patients. The reversal of the backward 
bowing of the lamina cribrosa may bring about a mechanical relief of stretching, 
compression, and strangulation on axons and capillaries.11 It appears that in 
patients with long standing increased lOP's, there may be a reversal of the 
cup/disc ratio but not an improvement in visual field with a decrease in the lOP. 
Visual field improvement occurs more often in cases where cupping of the optic 
disc does not extend to the edge of the disc. Visual field improvement occurs 
less in cases involving total loss of neuroretinal rim tissue, as seen in long 
standing lOP elevation. Even so, improvement in the appearance of the optic 
disc has been shown to accompany improvement in the visual field of many 
glaucoma patients.1o Though the data is grim, chronically elevated lOP should 
not be ignored. Rehabilitation of some of the compromised, but not atrophied, 
optic nerve fibers may occur with treatment. 
Reversibility of glaucomatous disc changes has been an accepted 
phenomenon in infantile and juvenile glaucomas.12 Adult reversibility has been 
noted in recent literature on a less frequent basis. There are at least two 
possible explanations for this difference. One, the immature eye may be more 
plastic than the older eye. Two, reversible cupping in older eyes may be more 
subtle and hence often missed. Perhaps the reversal in older patients is often 
unnoticed because observers do not expect change and therefore fail to look for 
it. 10 
The idea of reversing damage to the optic nerve opens new doors for 
treatment of glaucoma, but the prevalence and clinical significance has not 
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been established. More studies are needed to determine what percentage of 
reduction in lOP might be necessary to see cup/disc ratio reversibility and which 
patients are likely to demonstrate such reversibility. 
VISUAL FIELDS 
In general, an association between high lOP and the development of 
glaucomatous visual field loss is well accepted. However, recent studies have 
shown that such a correlation is not clear and direct. Until recently the 
possibility of reversibility of visual field loss was not considered. Now several 
studies have reported a visual field improvement with significant decrease in 
lOP. 2.10.11 The single point that appears to separate one study from another is 
the amount of lOP decrease needed to obtain a visual field reversal. All studies 
agree that a large reduction, in the range of 30-40% is necessary for visual field 
improvement. Thus, not unexpectedly, patients with POAG should show more 
improvement in perimetry results than those with low tension glaucoma. 
More studies are needed to explore the idea of visual field reversal with 
lOP reduction. For any treatment regimen to be considered a success, it must 
endure in the long term. In a study by Spaeth, of the 19% of patients presenting 
with visual field improvement none showed a deterioration during the time of 
the study.3 This was also evident in the study by Pectori-Giraldi previously 
mentioned in which stabilization and in some cases improvement of all 55 eyes 
was seen over the 3 years of the study.6 The endurance of treatment is yet 
another crucial area for further investigation. 
In a study by Tsai, the global indices were correlated to one another to rule 
out patient unreliability and familiarity with the perimeter as the cause of 
improved visual field. No correlation was found between an increase in visual 
7 
field and patient familiarity. The learning effect was minimal. Furthermore, it 
should be emphasized that the statistically significant improvement of visual 
field global indices was demonstrable mainly in patients with higher initial lOP 
level ·and larger magnitude of lOP reduction, rather than in all patients that 
showed optic disc cupping reversal after lOP reduction.11 
When treating glaucoma, controversies exist as to what stage of 
glaucoma is most successfu l in bringing about reversibilities in visual fields and 
optic nerve cupping. The most common and accepted theory, however, seems 
to point to early stages of glauacoma as having a higher prognosis for vision 
function improvement.4.7,13 Eyes with greater damage may require greater 
pressure reduction than healthier eyes for a disc and visual field improvement 
to become manifest. This is in agreement with the concept that visual field 
improvement is less likely to occur in patients with severe advanced cupping 
versus those with moderately damaged optic nerves. In addition, eyes with 
more severe cupping are more sensitive to elevated IOP.13 Demonstrable visual 
field changes have been noted with early to moderate glaucoma patients and 
not with the advanced glaucoma patientJ.11 
The lack of a consistent association between disc and visual field 
changes over time may be explained at least partially by the current limitations 
of perimetry and optic disc analysis. With the better quantification and increased 
sensitivity that will become possible with more sophisticated technology, such 
as computerized imaging, a greater correlation of visual field and optic disc 
changes may be detectable. The validity and consequence of timely treatment 
may need further study as technology increases to he lp obtain a true 
correlation. 
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CONCLUSION 
Perhaps in the future we might find cause to change our therapeutic goals in 
an attempt to achieve reversal of optic nerve cupping and visual field loss. 
However, at present, our goal as clinicians should be to keep lOP's low enough 
to prevent progressive damage to the disc and progressive field loss. Estimates 
show a 30-40% decrease or more as being most beneficial. Furthermore, the 
development of sensitive and reproducible methods for measuring visual fields, 
such as automated perimetry, and optic discs such as photogrammetry and 
computerized image analysis, may show that reversibility of field and disc 
changes occurs more often than has previously been appreciated. These are 
the avenues that will lead to better management of glaucoma patients due to 
dependable feedback mechanisms. lOP reduction seems to vary from one 
individual to another, and from one study to another. In our opinion this is not a 
question of each study's validity, but rather of the importance of "individual" 
glaucoma management. 
Another problem with glaucoma evaluation and management is the lack 
of a clear definition concerning the progression of the disease. There is no 
unanimous opinion on what constitutes the first signs of glaucomatous damage 
and when a glaucoma suspect become an established glaucoma patient. As 
revealed in this literature review, early to moderate glaucoma management 
holds the highest prognosis for visual function improvementJ.11 Further study 
is needed to address the relationship of optic cup reversal and visual field 
reversal with lOP decrease. The ideal definition of glaucoma control is a 
lowering of ocular pressure associated with an improvement in the disc and 
visual field. 12 The ideas of reversals in optic disk cupping and visual fields are 
exciting and encouraging. Too many variables still exist to determine exact 
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standards for therapy and management to obtain these reversals. It is important 
that clinicians begin to look for these reversible signs in their glaucoma patients. 
Soon, because of technological advances, glaucoma management will have a 
protocol that can be followed and lead to the desired reversibilities in most or all 
patients. 
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